/

Companies / Mana.bio

Mana.bio

Tel Aviv-Yafo, Israel

Mana.bio is an AI based drug delivery startup, focusing on gene therapy including DNA and RNA-based therapeutics, and vaccines.

Mana.bio, based in Tel Aviv-Yafo, Israel, has 5 investors on file, among them Andreessen Horowitz, Base4 Capital LP and LionBird. Its latest round on record is Seed, 10 Oct 2023. Its site was last checked 13 Nov 2026: site answers.

Funding

1 round on record
Latest roundSeed10 Oct 2023
Since that round3 years 1 monthno later round on record
Investors in its rounds55 with a VCinfo profile

Round sizes and total raised are on Fundup AI, our sister product for funding data.

Investors

5 investors on file
InvestorEvidenceType
Andreessen HorowitzPage + roundVenture capital
Base4 Capital LPPortfolio pageVenture capital
LionBirdPage + roundVenture capital
NFXPage + roundVenture capital
T3 – Technion Technology TransferPage + roundInvestor

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Mana.bio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when Andreessen Horowitz adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/mana.bio/investors

# also
GET /v1/companies/mana.bio
GET /v1/companies/mana.bio/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing